Breast cancer cells survive chemotherapy by activating targetable immune-modulatory programs characterized by PD-L1 or CD80.

Saved in:
Bibliographic Details
Title: Breast cancer cells survive chemotherapy by activating targetable immune-modulatory programs characterized by PD-L1 or CD80.
Authors: Shahbandi A; Department of Biochemistry and Molecular Biology, Tulane School of Medicine, New Orleans, LA, USA., Chiu FY; Department of Biochemistry and Molecular Biology, Tulane School of Medicine, New Orleans, LA, USA., Ungerleider NA; Department of Pathology, Tulane University School of Medicine, New Orleans, LA, USA., Kvadas R; Department of Biochemistry and Molecular Biology, Tulane School of Medicine, New Orleans, LA, USA., Mheidly Z; Department of Biochemistry and Molecular Biology, Tulane School of Medicine, New Orleans, LA, USA., Sun MJS; Department of Biochemistry and Molecular Biology, Tulane School of Medicine, New Orleans, LA, USA., Tian D; Department of Pathology, Tulane University School of Medicine, New Orleans, LA, USA., Waizman DA; Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA., Anderson AY; Department of Biochemistry and Molecular Biology, Tulane School of Medicine, New Orleans, LA, USA., Machado HL; Department of Biochemistry and Molecular Biology, Tulane School of Medicine, New Orleans, LA, USA., Pursell ZF; Department of Biochemistry and Molecular Biology, Tulane School of Medicine, New Orleans, LA, USA., Rao SG; Department of Biochemistry and Molecular Biology, Tulane School of Medicine, New Orleans, LA, USA., Jackson JG; Department of Biochemistry and Molecular Biology, Tulane School of Medicine, New Orleans, LA, USA. jjacks8@tulane.edu.
Source: Nature cancer [Nat Cancer] 2022 Dec; Vol. 3 (12), pp. 1513-1533. Date of Electronic Publication: 2022 Dec 08.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101761119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2662-1347 (Electronic) Linking ISSN: 26621347 NLM ISO Abbreviation: Nat Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2662-1347
DOI:10.1038/s43018-022-00466-y